Cost-effectiveness per DALY saved (2005 US$) of each POC test using Tanzanian life expectancy. Uncertainty bounds are in brackets
| POC test | Test done on serum* | Test done on blood† | ||||
|---|---|---|---|---|---|---|
| DALYs saved | Cost/DALY saved | % of RPR cost/DALY saved | DALYs saved | Cost/DALY saved | % of RPR cost/DALY saved | |
| *The impact and cost-effectiveness estimates for when the POC test is done on serum use sensitivity and specificity estimates derived from the reference laboratory. | ||||||
| † The impact and cost-effectiveness estimates for when the POC test is done on blood use sensitivity and specificity estimates derived from antenatal clinic. | ||||||
| DALY, disability-adjusted life year; POC, point-of-care; RPR, rapid plasma reagin. | ||||||
| RPR test | 1321 | 12.0 | 100% | |||
| Determine (Abbot) | 1316 (746–1532) | 17.0 (14.3–29.5) | 141% (119–247%) | 1309 (681–1529) | 16.8 (14.0–31.5) | 140% (117–263%) |
| Visitect (Omega) | 1373 (877–1532) | 14.3 (12.6–22.4) | 119% (105–187%) | 1373 (935–1531) | 14.1 (12.4–20.7) | 118% (104–173%) |
| Syphcheck (Qualpro) | 1390 (887–1531) | 14.1 (12.6–21.9) | 118% (105–183%) | 1397 (972–1532) | 13.9 (12.5–19.7) | 116% (104–164%) |
| Bioline (Standard) | 1430 (1127–1532) | 11.8 (10.9–15.0) | 99% (91–125%) | 1372 (914–1530) | 12.1 (10.7–18.1) | 101% (89–151%) |